Aytu BioScience, Inc. (NASDAQ: AYTU) Starts Presentation at LD Micro Main Event
Aytu BioScience (NASDAQ: AYTU) is a commercial-stage specialty life sciences company focused on global commercialization of novel products in the field of urology, with a focus on products addressing vitality, sexual wellness, and reproductive health. The company currently markets two prescription products in the U.S.: Natesto®, the first and only FDA-approved nasal formulation of testosterone for men with hypogonadism (low testosterone, or “Low T”) and ProstaScint®, the only FDA-approved imaging agent specific to prostate specific membrane antigen for prostate cancer detection and staging. For more information, visit the company’s website at www.aytubio.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service…







